BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23077952)

  • 1. Behavioral involvement of imidazoline system.
    Nechifor M; Ciubotariu D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):552-6. PubMed ID: 23077952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of imidazoline system in drug addiction.
    Ciubotariu D; Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1118-22. PubMed ID: 23700899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
    Nikolic K; Agbaba D
    Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazoline Receptor System: The Past, the Present, and the Future.
    Bousquet P; Hudson A; García-Sevilla JA; Li JX
    Pharmacol Rev; 2020 Jan; 72(1):50-79. PubMed ID: 31819014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the imidazoline receptors in toxicology.
    Lowry JA; Brown JT
    Clin Toxicol (Phila); 2014 Jun; 52(5):454-69. PubMed ID: 24666288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysing the effect of I
    Fehér Á; Tóth VE; Al-Khrasani M; Balogh M; Lázár B; Helyes Z; Gyires K; Zádori ZS
    Inflammopharmacology; 2017 Feb; 25(1):107-118. PubMed ID: 27873165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist.
    Turcani M
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):524-35. PubMed ID: 19034032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imidazoline receptors].
    Gongadze NV; Antelava NA; Kezeli TD
    Georgian Med News; 2008; (160-161):44-7. PubMed ID: 18711237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study of selective I1-imidazoline receptor ligands.
    Nikolic K; Filipic S; Agbaba D
    SAR QSAR Environ Res; 2009; 20(1-2):133-44. PubMed ID: 19343588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
    Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
    J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, localization and functional analysis of imidazoline and alpha adrenergic receptors in canine prostate.
    Felsen D; Ernsberger P; Sutaria PM; Nejat RJ; Nguyen P; May M; Breslin DS; Marion DN; Vaughan ED
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1063-71. PubMed ID: 7509387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imidazoline receptors. Historic review and current status of knowledge].
    Moura D
    Acta Med Port; 1993 Dec; 6(12):599-604. PubMed ID: 8165931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression.
    Piletz JE; Halaris A; Ernsberger PR
    Crit Rev Neurobiol; 1994; 9(1):29-66. PubMed ID: 8828003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.